Results 181 to 190 of about 574,463 (401)

About the Performance of Latin American Gynecology and Obstetrics Journals in the International Scenario. [PDF]

Rev Bras Ginecol Obstet, 2022
Sá MFS.
europepmc   +1 more source

Introduction to the course of obstetrics and gynecology in connection with clinical methods of teaching

, 1898
A. A. Muratov
openalex   +2 more sources

Predictive biomarkers for regression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2: A prospective multicenter study in Italy

International Journal of Cancer, EarlyView.
What's New? Cervical intraepithelial neoplasia grade 2 (CIN2) lesions can spontaneously regress, especially in women aged under 30. Better predictive biomarkers are needed to improve risk stratification for active surveillance. This prospective multicenter cohort study evaluated HPV genotyping, p16/ki67 expression, and FAM19A4/miR124‐2 methylation ...
Helena Frayle, Silvia Gori, Alessio Pagan, Marika Soldà, Cesare Romagnolo, Egle Insacco, Licia Laurino, Mario Matteucci, Giuseppe Sordi, Enrico Busato, Manuel Zorzi, Tiziano Maggino, Annarosa Del Mistro, CIN2 Study Working Group, Annarosa Del Mistro, Helena Frayle, Silvia Gori, Rossana Trevisan, Alessio Pagan, Justyna Wojciechowska, Enrico Busato, Tiziano Maggino, Marika Soldà, Cesare Romagnolo, Licia Laurino, Pamela Zambenedetti, Egle Insacco, Mario Matteucci, Maria Teresa Gervasi, Giuseppe Sordi, Marco Torrazzina, Manuel Zorzi, Daria Minucci   +32 more
wiley   +1 more source

Assessing Endoscopic Suture Performance of Gynecology and Obstetrics Residents Following Methodic Training. [PDF]

Rev Bras Ginecol Obstet, 2023
Nogueira LR, Lustosa KA, Galindo LAO, Castro SE, Picanço LR, Silva LLD, Coutinho SS, Bezerra LRPS.   +7 more
europepmc   +1 more source

Diagnostic tasks for obstetrics and gynecology

, 1895
N. Kakushkin
openalex   +2 more sources

Anti‐Her2 therapy patterns in metastatic breast cancer—Real‐world data suggest undertreatment

International Journal of Cancer, EarlyView.
What's New? Although human epidermal growth factor 2‐positive (HER2+) breast cancer is an aggressive malignancy, significant survival benefits are possible with targeted anti‐HER2 therapies. Whether these therapies are used as recommended, however, is unknown. Here, the authors investigated data from population‐based registries in Norway to assess anti‐
Kathrine F. Vandraas, Sarah Hjorth, Cassia B. Trewin‐Nybråten, Giske Ursin, Edoardo Botteri, Bettina Kulle Andreassen, Kristin V. Reinertsen, Egil S. Blix, Bjørn Naume, Nathalie C. Støer   +9 more
wiley   +1 more source

Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytoreduction Still Matters. [PDF]

Cancer Control, 2023
Xiao Y, Linghu H.
europepmc   +1 more source

Long‐term human papillomavirus genotype‐specific risk of cervical high‐grade intraepithelial lesion and cancer—By age group and triage cytology

International Journal of Cancer, EarlyView.
What's New? Human papillomavirus (HPV) testing has revolutionized cervical cancer screening. Nonetheless, its optimal use for distinguishing between high‐ and low‐risk infections to leverage screening benefits remains to be established. Here, long‐term HPV genotype‐specific risk of precancerous cervical intraepithelial neoplasia grade 2 or higher was ...
Maija Vahteristo, Sirpa Heinävaara, Joakim Dillner, Ilkka Kalliala, Pekka Nieminen, Tytti Sarkeala, Maarit K. Leinonen   +6 more
wiley   +1 more source

The Controversies and Challenges in the Management of Twin Pregnancy: From the Perspective of International Federation of Gynecology and Obstetrics Guidelines. [PDF]

Matern Fetal Med, 2022
Liu J, Liu Q, Zhao J, Li D, Zhou Y.
europepmc   +1 more source

CLINICAL TRAINING IN OBSTETRICS AND GYNECOLOGY

, 1928
NULL AUTHOR_ID
openalex   +1 more source